Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial

Marina Garassino; Julien Mazieres; Martin Reck; Christos Chouaid; Helge Bischoff; Niels Reinmuth; Laura Cove-Smith; Talal Mansy; Diego Cortinovis; Maria Migliorino; Angelo Delmonte; José Garcia Sánchez; Luis Enrique Chara Velarde; Reyes Bernabe; Luis Paz-Ares; Ignacio Diaz Perez; Nataliya Trunova; Kayhan Foroutanpour; Corinne Faivre-Finn

doi:10.1016/j.jtho.2022.07.1148

Journal Articles Journal of Thoracic Oncology Year : 2022

Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial

(1) , (2) , (3) , (4) , (5) , (6) , (7) , (8) , (9) , (10) , (11) , (12) , (13) , (14) , (15) , (16) , (16) , (16) , (17)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17

Marina Garassino

Function : Author

IRCCS Istituto Nazionale dei Tumori [Milano]

Julien Mazieres

Function : Author

Service de pneumologie [Toulouse]

Martin Reck

Function : Author

German Center for Lung Research

Christos Chouaid

Function : Author

IMRB - CEPIA/"Clinical Epidemiology And Ageing : Geriatrics, Primary Care and Public Health" [Créteil]

Helge Bischoff

Function : Author

fThoraxklinik Heidelberg

Niels Reinmuth

Function : Author

Asklepios Klinikum Uckermark GmbH

Laura Cove-Smith

Function : Author

The Christie NHS Foundation Trust and Manchester University Hospitals Foundation Trust

Talal Mansy

Function : Author

South Tees Hospitals NHS Foundation Trust

Diego Cortinovis

Function : Author

San Gerardo Hospital [Monza, Italy]

Maria Migliorino

Function : Author

San Camillo Forlanini Hospital [Rome]

Angelo Delmonte

Function : Author

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS

José Garcia Sánchez

Function : Author

Arnau de Vilanova University Hospital [Lleida, Spain]

Luis Enrique Chara Velarde

Function : Author

Hospital Universitario de Guadalajara

Reyes Bernabe

Function : Author

Hospital Universitario Virgen del Rocío [Sevilla]

Luis Paz-Ares

Function : Author

Universidad Complutense de Madrid = Complutense University of Madrid [Madrid]

Ignacio Diaz Perez

Function : Author

AstraZeneca, Gaithersburg, Maryland, United States.

Nataliya Trunova

Function : Author

AstraZeneca, Gaithersburg, Maryland, United States.

Kayhan Foroutanpour

Function : Author

AstraZeneca, Gaithersburg, Maryland, United States.

Corinne Faivre-Finn

Function : Author

University of Manchester [Manchester]

Keywords

Durvalumab Immunotherapy Locally advanced Non–small-cell lung cancer Sequential chemoradiotherapy

Domains

Cancer Santé publique et épidémiologie

Fichier principal

PIIS1556086422015003.pdf (353.86 Ko)

Origin	Publication funded by an institution

Claudia Tapia : Connect in order to contact the contributor

https://hal.u-pec.fr/hal-04141429

Submitted on : Monday, June 26, 2023-11:49:57 AM

Last modification on : Tuesday, October 31, 2023-11:26:05 AM

Long-term archiving on : Wednesday, September 27, 2023-7:39:59 PM

Dates and versions

hal-04141429 , version 1 (26-06-2023)

Identifiers

HAL Id : hal-04141429 , version 1
DOI : 10.1016/j.jtho.2022.07.1148

Cite

Marina Garassino, Julien Mazieres, Martin Reck, Christos Chouaid, Helge Bischoff, et al.. Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial. Journal of Thoracic Oncology, 2022, 17 (12), pp.1415-1427. ⟨10.1016/j.jtho.2022.07.1148⟩. ⟨hal-04141429⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

IMRB UPEC

3 View

29 Download

Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial

Keywords

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share